Band of Parents
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)(Learn how and when to remove this template message)
The Band of Parents is a 501c3 nonprofit organization. Formed in July 2007 and incorporated in October 2007, it was founded by approximately 100 parents of young children with neuroblastoma who were treated at Memorial Sloan Kettering Cancer Center (MSKCC). Its purpose is to fund the development of new therapies for neuroblastoma that would not otherwise be pursued by research institutions or the pharmaceutical industry. The organization has become the largest single funder of neuroblastoma research at MSKCC.
Neuroblastoma is a form of childhood cancer that can develop at any age but typically presents between the ages of 18 months and five years. It affects a little over 600 children per year in the United States. Most are diagnosed with stage IV disease, the most advanced form. Even with aggressive therapy, stage IV neuroblastoma carries a poor prognosis, with a three-year survival rate of 30–40%.
Compared with other types of cancer, neuroblastoma is rare. Scientific advances have allowed the development of individualized treatments, with techniques such as immunotherapy being targeted to specific kinds of cancer. However, because of the rising cost of drug development, which is approaching $1 billion, pharmaceutical companies are not likely to develop drugs that are specific to neuroblastoma or other rare disorders.
The Band of Parents' first project was the development of a humanized antibody, Hu3F8.
In addition to surgery, chemotherapy and radiation, many neuroblastoma patients at MSKCC were treated with a murine (mouse-derived) monoclonal antibody called 3F8. Given intravenously, 3F8 binds specifically to neuroblastoma cells and triggers an immune response, which destroys the cancerous cells. Because the antibody also binds to peripheral nerve cells, the treatment is painful, but it is generally without long-term complications. However, its use is limited by the body's eventual development of human anti-murine antibody, which neutralizes the effects. The Band of Parents raised $2–$3 million to fund the genetic engineering of the murine cell line that produces 3F8 so that it would produce a new antibody, Hu3F8, using human genes. Hu3F8 has the same benefits as 3F8, but because it is 98% human, it does not cause a neutralizing immune response. In theory, this should allow patients to be treated with it indefinitely.
In March 2013, the Band of Parents led a group of nonprofit organizations in providing a $2 million grant to MSKCC to fund the development of a bispecific monoclonal antibody targeting neuroblastoma.
The organization's other projects have included the Loneliest Road Campaign, a 3,000-mile, 19-day bicycle ride across the US by six fathers of children in active treatment; a bake sale with cookies made by the children, their families and supporters; and The BoP Shop, an online store featuring artwork by children with neuroblastoma.
In 2012, the Band of Parents began an annual gala event called the Evening of Hope, which has become its primary fundraiser.
- "Father of Talia Castellano seeks cure for cancer". NY Daily News. Retrieved 2016-05-21.
- "The Honor Roll - Giving to Memorial Sloan Kettering". mskcc.convio.net. Retrieved 2016-05-21.
- "Memorial Sloan-Kettering Cancer Center 2011 Annual Report" (PDF). p. 52.
- "Memorial Sloan-Kettering Cancer Center 2012 Annual Report" (PDF). p. 27.
- Schmidt ML, Lal A, Seeger RC, et al. (September 2005). "Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study". J. Clin. Oncol. 23 (27): 6474–80. doi:10.1200/JCO.2005.05.183. PMID 16116154.
- http://www.stayclassy.org/stories/the-band-of-parents-evening-of-hope-benefit-raising-over-150000-for-neuroblastoma-research[permanent dead link]